摘要:BACKGROUND: Scientists and clinicians still look for satisfactory treatment for post-stroke spasticity, especially within long-term neurorehabilitation. Relatively novel therapeutic method is use of botulinum toxin type A (BTX-A). OBJECTIVE: Contrary to the previous studies we focused on late post-stroke population. This study aims at showing such patients profiles. CASE STUDIES PRESENTATION: We decribe a convenience sample cases study analysis of six adult patients with post-stroke spasticity (mean time after cerebrovascular accident: 7.5 years) admitted to the neurological rehabilitation ward. CONCLUSIONS: Despite BTX-A is one of the most potent antispastic medications details of its optimal application and effectiveness within long-term naurorehabilitation of adults are still in the process of being confirmed. Current health status, secondary changes and complications, individual therapeutic goals and functional skills expected to achieve in particular case may significantly modify way of the therapy.